Riccardo Castagnoli

Citée par

	Toutes	Depuis 2020
Citations	8956	8500
indice h	35	34
indice i10	82	80

2200

1100

550

1650

201620172018201920202021202220232024202536 53 105 191 852 2131 2038 1695 1467 228

Accès public

Tout afficher

35 articles

0 article

disponibles

non disponibles

Sur la base des exigences liées au financement

Coauteurs

Amelia LicariUniversità degli Studi di PaviaAdresse e-mail validée de unipv.it
martina vottoUniversity of PaviaAdresse e-mail validée de universitadipavia.it
Luigi Daniele NotarangeloNational Institute of Allergy and Infectious Diseases, NIHAdresse e-mail validée de nih.gov
Stefania Arasi, MD, PhD, MScBambino Gesù HospitalAdresse e-mail validée de opbg.net
Ottavia DelmonteNational Institutes of healthAdresse e-mail validée de nih.gov
Luca PecoraroPediatrician, University of Verona; ASST MantuaAdresse e-mail validée de asst-mantova.it
Elio NovembreProfessore Associato di Clinica PediatricaAdresse e-mail validée de unifi.it
Carla MastrorilliUO Pediatria e Pronto Soccorso AUO Policlinico Bari - Ospedale Giovanni XXIIIAdresse e-mail validée de policlinico.ba.it
Francesca MoriAllergy Unit, Anna Meyer Children's University Hospital, FlorenceAdresse e-mail validée de meyer.it
Maria Angela ToscaISTITUTO G. GASLINIAdresse e-mail validée de gaslini.org
Stefano PerliniUniversity of PaviaAdresse e-mail validée de unipv.it
Bruno Raffaele,MDProfessor of Infectious DiseasesAdresse e-mail validée de unipv.it
Silvia FedericiOspedale pediatrico Bambino Gesù, RomaAdresse e-mail validée de opbg.net
Stefano VolpiIstituto Giannina Gaslini, Università degli Studi di Genova, Harvard Medical SchoolAdresse e-mail validée de gaslini.org
salvatore leonardiDepartment of Pediatrics. University of CataniaAdresse e-mail validée de unict.it
Kerry DobbsJURA Bio, Inc.Adresse e-mail validée de jurabio.com
Enrica CalzoniColumbia UniversityAdresse e-mail validée de cumc.columbia.edu
Elena ChiappiniOspedale Meyer, Università degli Studi di FirenzeAdresse e-mail validée de meyer.it
Francesca PalaNIAID, NIHAdresse e-mail validée de nih.gov
linda rossiniMD, Pediatrician at Padua University Hospital, PhD Student at Padua UniversityAdresse e-mail validée de aopd.veneto.it

Suivre

Riccardo Castagnoli

University of Pavia, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy

Adresse e-mail validée de unipv.it - Page d'accueil

Inborn errors of immunity Genetics COVID-19 MIS-C


Titre Trier par citations Trier par année Trier par titre	Citée par Citée par	Année
Autoantibodies against type I IFNs in patients with life-threatening COVID-19 P Bastard, LB Rosen, Q Zhang, E Michailidis, HH Hoffmann, Y Zhang, ... Science 370 (6515), eabd4585, 2020	2750	2020
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in children and adolescents: a systematic review R Castagnoli, M Votto, A Licari, I Brambilla, R Bruno, S Perlini, F Rovida, ... JAMA pediatrics 174 (9), 882-889, 2020	1419	2020
Autoantibodies neutralizing type I IFNs are present in~ 4% of uninfected individuals over 70 years old and account for~ 20% of COVID-19 deaths P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, J Manry, ... Science immunology 6 (62), eabl4340, 2021	539	2021
An immune-based biomarker signature is associated with mortality in COVID-19 patients MS Abers, OM Delmonte, EE Ricotta, J Fintzi, DL Fink, AAA de Jesus, ... JCI insight 6 (1), e144455, 2021	359	2021
Immunopathological signatures in multisystem inflammatory syndrome in children and pediatric COVID-19 K Sacco, R Castagnoli, S Vakkilainen, C Liu, OM Delmonte, C Oguz, ... Nature medicine 28 (5), 1050-1062, 2022	224	2022
Hematopoietic stem cell transplantation in primary immunodeficiency diseases: current status and future perspectives R Castagnoli, OM Delmonte, E Calzoni, LD Notarangelo Frontiers in pediatrics 7, 295, 2019	209	2019
Asthma endotyping and biomarkers in childhood asthma A Licari, R Castagnoli, I Brambilla, A Marseglia, MA Tosca, GL Marseglia, ... Pediatric allergy, immunology, and pulmonology 31 (2), 44-55, 2018	190	2018
The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies J Manry, P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, ... Proceedings of the National Academy of Sciences 119 (21), 2022	169	2022
The nose and the lung: united airway disease? A Licari, R Castagnoli, CF Denicolò, L Rossini, A Marseglia, GL Marseglia Frontiers in Pediatrics 5, 44, 2017	144	2017
HGID Lab P Bastard, LB Rosen, Q Zhang, E Michailidis, HH Hoffmann, Y Zhang, ... NIAID-USUHS Immune Response to COVID Group, 2020	142	2020
Omalizumab in children A Licari, A Marseglia, S Caimmi, R Castagnoli, T Foiadelli, S Barberi, ... Pediatric Drugs 16, 491-502, 2014	119	2014
Autoantibodies against type I IFNs in patients with life-threatening COVID-19. Science. 370: eabd4585 P Bastard, LB Rosen, Q Zhang, E Michailidis, HH Hoffmann, Y Zhang, ...	95	2020
Inborn errors of immunity with immune dysregulation: from bench to bedside OM Delmonte, R Castagnoli, E Calzoni, LD Notarangelo Frontiers in pediatrics 7, 353, 2019	93	2019
Neutralizing type‐I interferon autoantibodies are associated with delayed viral clearance and intensive care unit admission in patients with COVID‐19 MS Abers, LB Rosen, OM Delmonte, E Shaw, P Bastard, L Imberti, ... Immunology and cell biology 99 (9), 917-921, 2021	89	2021
From IgE to clinical trials of allergic rhinitis G Ciprandi, GL Marseglia, R Castagnoli, C Valsecchi, C Tagliacarne, ... Expert review of clinical immunology 11 (12), 1321-1333, 2015	87	2015
Allergy and asthma in children and adolescents during the COVID outbreak: what we know and how we could prevent allergy and asthma flares A Licari, M Votto, I Brambilla, R Castagnoli, E Piccotti, R Olcese, ... Allergy 75 (9), 2402, 2020	86	2020
The discovery and development of omalizumab for the treatment of asthma A Licari, GL Marseglia, R Castagnoli, A Marseglia, G Ciprandi Expert opinion on drug discovery 10 (9), 1033-1042, 2015	83	2015
Autoantibodies against type I IFNs in patients with critical influenza pneumonia Q Zhang, A Pizzorno, L Miorin, P Bastard, A Gervais, T Le Voyer, L Bizien, ... Journal of Experimental Medicine 219 (11), e20220514, 2022	81	2022
Dupilumab to treat type 2 inflammatory diseases in children and adolescents A Licari, R Castagnoli, A Marseglia, F Olivero, M Votto, G Ciprandi, ... Pediatric Drugs 22 (3), 295-310, 2020	80	2020
Eosinophilic gastrointestinal diseases in children: a practical review A Licari, M Votto, E D'Auria, R Castagnoli, SME Caimmi, GL Marseglia Current pediatric reviews 16 (2), 106-114, 2020	78	2020

Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.

Articles 1–20

Nombre de citations par an

Citations en double

Citations fusionnées

Ajouter les coauteursCoauteurs

Suivre

Citée par

Coauteurs